LISAvienna: Webinar-Reihe zur Herstellung von Persönlicher Schutzausrüstung
LISAvienna veranstaltet im April erstmals eine virtuelle Business Treff Reihe.
LISAvienna Newsletter: Corona Virus Special Edition
Austria's life sciences sector is mobilizing against the SARS-CoV-2 pandemic – from clinics to research institutions and…
LISAvienna: January 2020 newsletter available now
Today, we for example highlight news items from the following companies and research institutions from Vienna in our…
LISAvienna newsletter: December edition distributed today
Our newsletter keeps you up-to-date on the life sciences in Vienna. Today, we for example highlight news from Apeptico,…
LISAvienna: Fotos und Vortragsunterlagen Regulatory Konferenz für Medizinprodukte und IVD 2019
Mit einer Rekordzahl von über 350 Anmeldungen übertraf die Regulatory Konferenz für Medizinprodukte und IVD 2019 alle…
LISAvienna: Read the November edition of our Newsletter
This time, we e.g. feature news from ABF Pharmaceutical Services, Ares Genetics, a:head, BOKU, contextflow, Diagnosia,…
LISAvienna: October newsletter available now
Enjoy reading today’s newsletter! This time, we e.g. feature news from ARCHIMEDlife, Cubicure, EveliQure, Evologic…
LISAvienna: Enjoy reading today’s newsletter
Our electronic newsletter focuses on the life sciences in Vienna. Today, we for example update you on Ares Genetics,…
LISAvienna’s August e-Newsletter available now
Our electronic newsletter keeps you up-to-date on the life sciences in Vienna. Today, we highlight news from a:head bio,…
LISAvienna: New newsletter edition distributed today
Our newsletter keeps you up-to-date on the life sciences in Vienna. Today, we for example highlight news from acib,…
LISAvienna: May newsletter available online
Our newsletter keeps you up-to-date on biotech and medtech in Vienna. We also include event tips and some information on…
LISAvienna: April Newsletter available as of now
Did you receive our electronic newsletter today? This time, we are highlighting news from 123sonography, AIT, Ares…